Recent Headlines
Within Chemical Manufacturing
Vivisum Partners Publishes Strategic Analysis on the Ulcerative Colitis Marketplace
Among branded ulcerative colitis treatments, 84% of US gastroenterologists expect Zeposia to see an increase in prescription volume over the next 12 months, according to new research on the ulcerative colitis marketplace published by Vivisum Partners. Vivisum Partners has just published its... - October 25, 2022 - Vivisum Partners, LLC
New Market Insights on the Best MS Treatment Published by Vivisum Partners
What’s the best MS treatment according to neurologists? The question of how to assess the ideal drug to treat multiple sclerosis is difficult to answer. Neurologists determine which clinical attributes take higher priority for each patient. Vivisum Partners, LLC, a market research firm in... - October 24, 2022 - Vivisum Partners, LLC
ARA Breast Radiologist Goes All Pink to Emphasize Importance of Mammography
It’s Breast Cancer Awareness Month and many are working to bring attention to breast cancer and the importance of screening with mammography. However, Dr. Arthy Saravanan, head of the breast imaging section at ARA Diagnostic Imaging, is going the extra mile, in a bright pink car. Dr. - October 18, 2022 - ARA Diagnostic Imaging
Huntington Study Group Announces myHDstory™ Pilot Study: Making HD Voices Heard Has Reached Target Enrollment
The Huntington Study Group (HSG), a world leader in clinical research for Huntington’s Disease (HD) for over 30 years, is pleased to announce that the pilot study, Making HD Voices Heard, on the new online research platform, myHDstory™, has reached its enrollment target. “The HSG... - October 18, 2022 - Huntington Study Group
Kantify and Mcule Harness the Power of Data to Accelerate Drug Discovery
Kantify, using its AI technology for drug discovery and Mcule, with its compound sourcing platform, are collaborating to leverage data for better hit prediction. - October 17, 2022 - Mcule
Thrivous Releases Serenity Nightly Nootropic Formula 3
Thrivous, the human enhancement company, has released Serenity Nightly Nootropic Formula 3 with KSM-66® Ashwagandha. Serenity is the advanced nootropic supplement that Thrivous develops to enhance relaxation, sleep, and next-day focus. Serenity combines nootropic nutrients with the highest... - October 14, 2022 - Thrivous
High-Standard Fermented Raw Materials That Satisfy the Quality Attributes of Healthcare Products
BOC Sciences is able to provide clients with high-standard fermented raw materials that satisfy the quality attributes of finished healthcare products. - October 13, 2022 - BOC Sciences
Huntington Study Group Enrolls First Participant for Its Observational Study to Test the Reliability of the Virtual Use of the Unified Huntington’s Disease Rating Scale
The Huntington Study Group (HSG), a world leader in conducting clinical trials for Huntington’s Disease (HD) for over 30 years, together with its Clinical Research Organization (“CRO”), the HSG Clinical Research, Inc., today announces the enrollment of the first participant of its... - October 12, 2022 - Huntington Study Group
BOC Sciences Declares the Availability of 10,000 Impurities, All in Stock
BOC Sciences recently confirmed to its customers that over 10,000 impurities are now in stock, ready for immediate delivery. - October 12, 2022 - BOC Sciences
Mirror Biologics, Inc. Announces Additional $20 Million Investment to Close Out $30 Million Series A Investment Round
Mirror Biologics, Inc., a clinical stage biopharmaceutical company today announced the completion of the final $20 million tranche of its $30 million Series A investment round with Bradbury Asset Management (Hong Kong), Limited. Bradbury provided an initial $10 million tranche for this round in... - October 11, 2022 - Mirror Biologics, Inc.
SYNG Pharmaceuticals Announces Issuance of Its Canadian Patent for Non-Hormonal Therapy for Endometriosis
SYNG Pharmaceuticals Inc. (SYNG), a Kingston, Ontario based women’s health biotech, is pleased to announce that on October 04, 2022, the Canadian Intellectual Property Office granted Canada Patent No. 2,903,608 titled, "Treatment of endometriosis, angiogenesis and/or endometrial lesion growth." - October 09, 2022 - SYNG Pharmaceuticals Inc.
Vivisum Partners' Research Finds New Ulcerative Colitis Drugs Provide Excitement to Gastroenterologists
Newly published research found that several new ulcerative colitis drugs currently in development are providing excitement among gastroenterologists eager to add additional medicines to their current treatment options. Based on a market analysis from Vivisum Partners, a market research and brand... - October 08, 2022 - Vivisum Partners, LLC
Tasly Pharmaceuticals to Exhibit at BioJapan 2022 -- Bio-Pharmaceutical Company to Join with Maryland-Based Organizations at Asia’s Premier Biotechnology Partnering Event
Tasly Pharmaceuticals will exhibit at BioJapan 2022, October 12-14 at PACIFICO Yokohama - October 05, 2022 - Tasly Pharmaceuticals, Inc.
Professional Plastics Expands U.S. Northeast Distribution Capabilities
A new facility in Angola doubles the company’s footprint in Western New York and advances its development of a distribution hub and continued growth in the region. - October 05, 2022 - Professional Plastics
Evidence Partners Rebrands as DistillerSR to Leverage Market Awareness of Its Core Literature Review Platform
The Company Also Bolstered Its Executive Team in Security, Product Management and Operations to Support Accelerating Growth - September 28, 2022 - DistillerSR
New Decentralized Clinical Trial (DCT) Patient Satisfaction and Participation Report
800 Current and Future Clinical Trial Participants Link Satisfaction and Willingness to Participate with Decentralized Strategies - September 21, 2022 - Life Science Strategy Group, LLC
Biomed Industries, Inc. to Acquire MedAware Systems, Inc. to Expand Its Artificial Intelligence Research for Drug Discovery in Alzheimer’s Disease
Biomed Industries, Inc. (“BIOMED” or the “Company”), has entered into a share exchange agreement to acquire all of the issued and outstanding shares of MedAware Systems, Inc. MedAware shares was valued at $1.50 per share and BIOMED’s share was valued at $8.00 per share. The transaction was valued at an aggregate of $18 million, to be paid in the form of 2,259,170 common shares of BIOMED. On the date of the Agreement, BIOMED has approximately 76,354,075 common shares. - September 21, 2022 - Biomed Industries, Inc.
From Road Crew to Rhino Shield. One Man’s Dream Come True.
Chris Curtis is a great example of what it takes to achieve the American dream. From meager beginnings working road construction to now owning his own Rhino Shield dealership, hard work and ingenuity paved the way for his success. When Curtis graduated in 1998, he had a dream that one day... - September 19, 2022 - Rhino Shield Columbus
MEDraysintell Publishes the 9th Edition of Its Nuclear Medicine Report & Directory
A set of three volumes (3,500 pages) with a description of 970 products, together with a comprehensive profile of 380 companies active around the world in the radiopharmaceutical industry. - September 16, 2022 - MEDraysintell
Micromed Diamond Seal Systems, Inc. Confirms its Helmet Glide Spray-On Nanotechnology Changes Views on Sports Injuries
A nanotechnology liquid contributes to the safety of football players in today's game, according to long-time college and professional football equipment manager Todd Hewitt. "It's the best thing since sliced bread." Helmet Glide is a liquid product that is sprayed on and wiped off football helmets. It reduces surface tension by more than 25% thereby decreasing the rotational friction. It also protects the helmets and masks, keeping them in play longer. HG has been used in all levels since 2013. - September 14, 2022 - Diamond Seal Systems, Inc.
BOC Sciences September Promotion: Comprehensive Labeled Peptides with Stable Quality
As a pioneer in stable isotopic labeling chemistry, BOC Sciences develops a large variety of SIL compounds. Its promotion of labeled peptides, the increasingly used materials for convenient detection in research, is on the boil in September. - September 14, 2022 - BOC Sciences
Appointments Made to the Sterile Compounding Expert Panel Announced by Pharmacy Stars
The Sterile Compounding Expert Panel (SCXP) was established by Pharmacy Stars on July 7, 2022. Pharmacy Stars executive leadership has appointed key members to serve on SCXP’s panel. They have joined in support of the organization’s mission to strengthen sterile compounding practices in... - September 12, 2022 - Pharmacy Stars, LLC
Brighton Fire Authority 9/11 Memorial Preserved by Rhino Shield of Michigan
The 9/11 Memorial at Brighton Fire Authority Main Headquarters has been encapsulated using a process that has sealed the steel memorial and protected it from corrosion and weather. The memorial was erected in 2011 in memory of the victims of the 9/11 attacks in New York, Pennsylvania, and the Pentagon. - September 07, 2022 - Rhino Shield of Michigan
BOC Sciences Yields Peptide-siRNA Conjugates of High Quality
BOC Sciences offers high-quality peptide-siRNA conjugates to help clients achieve substantial preclinical progress for RNAi therapeutics. - September 07, 2022 - BOC Sciences
GENINVO Service Offering Custom Application Development
GENINVO is a leading provider of high-quality, innovative life science tools. GENINVO understand the business challenges of enterprises big and small. Whether you need short-term, focused design support or turnkey product development, GENINVO has the right tools to meet your needs with the help of... - September 07, 2022 - GenInvo, Inc.
BOC Sciences Developed Strain Expression Systems to Enhance Fermentation Productivity
BOC Sciences developed strain expression systems for fermentation to help researchers greatly enhance fermentation productivity while significantly reducing costs. - September 02, 2022 - BOC Sciences
AeroGo Awarded 2022-2023 Great Place to Work Certification™
AeroGo is proud to announce that the company has been Certified™ by Great Place to Work®. The prestigious award is based entirely on what current employees say about their experience working at AeroGo. Great Place to Work® is the global authority on workplace culture, employee... - September 01, 2022 - AeroGo, Inc.
Paras Biopharmaceuticals Finland Oy Has Been Identified as One of the "Fastest Growing Companies in the Nordic Biotechnology Therapeutics & Diagnostics Industry"
Paras Biopharmaceuticals is pleased to announce that the company has been identified as one of the Fastest Growing Companies in the Nordic Biotechnology Therapeutics and Diagnostics industry by Plimsoll Publishing UK. - September 01, 2022 - Paras Biopharmaceuticals Finland Oy
Process Technology, Inc. is Now the Preferred Distributor for Dwyer Instrumentation Solutions for the Rocky Mountain Region
Process Technology, Inc. (PTI) has been making your applications work since 1986. They are committed to being recognized as the industry leader in process instrumentation and automation control. Learn more at www.process-tech.com. Dwyer is a trusted leader in manufacturing innovative... - August 31, 2022 - Process Technology, Inc.
CABRI Announces Call for Proposals on Specialized Pro-Resolving Mediator Analytical Methods
The Cayman Biomedical Research Institute (CABRI) is offering research grants in amounts up to $100,000 to support essential research on specialized pro-resolving mediator (SPM) analytical methods. - August 26, 2022 - Cayman Chemical Company
Deadline Extended: CABRI Announces Undergraduate Fellowships and Scholarship Program
The Cayman Biomedical Research Institute (CABRI) is accepting applications from undergraduate students who have been offered an unpaid laboratory research position under an accredited principal investigator. Applications will be accepted from August 22 until September 18, 2022. - August 26, 2022 - Cayman Chemical Company
Jillian Altizer Joins AeroGo as Human Resources Manager
Jillian Altizer Joins AeroGo as Human Resources Manager. - August 25, 2022 - AeroGo, Inc.
Triad Control Systems, LLC, a Full-Service Automation Company, Acquires Certain Assets of CJ Automation & Controls, LLC
Triad Control Systems, LLC (TCS) announced today that it has entered into an agreement to purchase certain assets and contracts of CJ Automation and Controls, LLC (CJAC). The transaction is scheduled to close on or about September 1, 2022. This acquisition will enhance TCS’s capabilities to... - August 25, 2022 - Triad Control Services
UnifyTwin Announce a Global Partnership with Technologies New Energy (TNE) for Smart Energy Solutions to Utilities & Manufacturers
UnifyTwin a leading Industry 5.0 company today announced that it has established a partnership with Technologies New Energy (TNE), a global provider of energy solutions, to provide Smart Energy Solutions. TNE will provide these solutions to the power & utilities sector across Europe and American markets leveraging the UnifyTwin Intelligent App Suite. - August 25, 2022 - UnifyTwin Inc.
Leaders in Soil Microbiology Announce Expansion in New HQ
Biome Makers, a global leader in soil microbiology, announced its expansion into a new headquarters in Davis, CA. The new Davis HQ will enable Biome Makers to scale operations and support the global demand for BeCrop® technology, the industry standard for soil health. Biome Makers' proprietary technology, BeCrop®, is utilized in 40+ countries, impacting over 417,000 hectares worldwide and empowering over 8,000 farmers to adopt regenerative practices and recover soil health. - August 19, 2022 - Biome Makers
Pharma CI Conference Returns Next Month: Meet Hundreds of Industry Leaders at the Top Event for 15+ Years
Ready, set, engage! The Pharma CI USA Conference & Exhibition is back in person and ready to deliver the industry-leading experience that has made Pharma CI the gold standard event for more than fifteen years. The much-anticipated return happens this September 21-22 at the Newark Liberty... - August 18, 2022 - Pharma CI Conference
S V Prasad Gandhikota Recognized for Dedication in the Manufacturing Industry
S V Prasad Gandhikota has been included in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into... - August 11, 2022 - Prasad Gandhikota
VMRD Begins Manufacturing Key Reagent for Detection of CWD by RT-QuIC
Veterinary Medical Research & Development (VMRD), Pullman, WA, has partnered with CWD Evolution, Fort Collins, CO, to provide state-of-the-art diagnostic reagents for detection of the abnormal prion associated with Chronic Wasting Disease (CWD). The control of CWD requires identification of... - August 09, 2022 - VMRD, Inc.
Peptineo, LLC Selected by EPA to Provide EPA Nationwide Coverage for Point of Care (POC) COVID-19 Testing
The Environmental Protection Agency (EPA), Cincinnati Acquisition Division (CAD), has awarded Peptineo LLC, an emerging aerospace, health services, and defense solutions company, a three-year Blanket Purchase Agreement (BPA) to support a comprehensive COVID-19 testing program in support of the... - August 07, 2022 - Peptineo
Stable and Quality Supply of Phosphoramidites is a Reality at BOC Sciences
As an expert in chemistry, BOC Sciences understands how important the quality of phosphoramidite is to successful oligo synthesis and remarkably, it has taken concrete actions to manufacture certified products. - August 05, 2022 - BOC Sciences
BOC Sciences Shares Its Strategic Emphasis on NTPs During the Pandemic
"Whether your studies involve DNA sequencing, cDNA synthesis, RT-PCR, RCA, MDA, DNA labeling, in vitro transcription, siRNA synthesis, or RNA amplification, we stock hundreds of modified or natural NTPs to suit your various molecular biological applications," a BOC Sciences manager announces to the public. - August 05, 2022 - BOC Sciences
ActivArmorTM Expands Partnership with Fusion3 to Offer In-Clinic Custom 3D Printed Plastic Cast Fabrication Nationwide
Developer of 3D printing casts & splints partners with the manufacturer of affordable, high-performance 3D printers to expand capabilities and distribution for FDA-approved, a breakthrough solution for doctor's offices, clinics, and hospitals. - July 26, 2022 - Fusion3
International Panel of Experts Provides Guidance on Key Questions in Risk Assessment of PFAS Chemicals
A new peer-reviewed report by a panel of scientists sheds new light on regulation and management of per- and polyfluoroalkyl substances (PFAS). SciPinion, which objectively engages the global scientific community to analyze the toughest scientific topics, today announced the publication of an... - July 19, 2022 - SciPinion
PharmStars Announces Spring 2022 Accelerator Graduates: 11 Digital Health Startups Have Successfully Completed PharmStars’ Pharma-Focused Accelerator Program
PharmStars, the pharma-focused accelerator for digital health startups, announces the graduation of 11 startups from its Spring 2022 program. The graduates successfully completed the 10-week PharmaU program, which culminated with the Showcase Event held June 8-10 in Boston. The Showcase Event brought together the participating startups and PharmStars’ seven innovation-minded pharma members. - July 12, 2022 - PharmStars
Pharmacy Stars’ New Sterile Compounding Quality Peer Network Aims to Fill the Role Once Held by the Now Discontinued CriticalPoint Peer Network
Pharmacy Stars to launch the Sterile Compounding Quality Peer Network with the goal of filling the vacated role of CriticalPoint’s Peer Network, an online forum designed to support 503A entities, their regulators, and their certifiers. The CriticalPoint Peer Network has been discontinued as of June 30, 2022, according to the CriticalPoint website. - July 11, 2022 - Pharmacy Stars, LLC
River Valley Relief Names Ryan Kenaga President
River Valley Relief (RVR), a family-owned medical cannabis cultivator located in Fort Smith, Arkansas makes some organizational changes and names new President. - July 08, 2022 - River Valley Relief
Global Cancer Technology Successfully Concludes Glioblastoma Pre-Clinical Animal Studies with Impressive Results
Global Cancer Technology, a San Diego, CA biotechnology company, has successfully completed animal testing with GCT.GLIO.1, a PI3K selective inhibitor that can cross the blood brain barrier and modulate immune cell function. The company will advance the compound to Phase 1 clinical trials as a next step. - July 08, 2022 - Global Cancer Technology
BOC Sciences Grandly Promotes: One-Stop CDMO Service Platform for Drug Development
BOC Sciences recently initiated an unprecedentedly comprehensive CDMO service platform to accelerate the technology transfer of medicines from research to commercial production. - July 06, 2022 - BOC Sciences
BOC Sciences Commitment at BIO 2022: From Concept to GMP Production
The BIO International Convention just ended on June 16 at San Diego Convention Center. BOC Sciences exhibited a whole set of preclinical CRO & fermentation CDMO services and attracted many interested visitors stopping by to have an informative in-person meeting. - July 06, 2022 - BOC Sciences
Don't Let Joint Pain Hold You Back
Adventist Health Simi Valley is Ventura County’s first Robotic Center of Excellence and provides the community with the latest joint-replacement techniques resulting in less pain, shorter hospital stays and quicker recoveries. - July 02, 2022 - Adventist Health